XTX Topco Ltd Q2 2021 Filing
Filed August 12, 2021
Portfolio Value
$296.8B
Holdings
769
Report Date
Q2 2021
Filing Type
13F-HR
All Holdings (769 positions)
| Stock | Value |
|---|---|
—TEAM INC | $68.0M |
TPIVDEURMARKER THERAPEUTICS INC | $67.0M |
ENICENEL CHILE S.A. | $67.0M |
—THERAPEUTICSMD INC | $67.0M |
GYRECATALYST BIOSCIENCES INC | $66.0M |
—CALITHERA BIOSCIENCES INC | $65.0M |
—AVINGER INC | $65.0M |
FSPFRANKLIN STR PPTYS CORP | $65.0M |
—OPTINOSE INC | $64.0M |
35VVEON LTD | $64.0M |
—CINEDIGM CORP | $63.0M |
HEBCHFAIM IMMUNOTECH INC | $63.0M |
LQDALIQUIDIA CORPORATION | $62.0M |
ENTXWENTERA BIO LTD | $62.0M |
—POLARITYTE INC | $61.0M |
ATYRATYR PHARMA INC | $60.0M |
SOSSOS LIMITED | $59.0M |
—CONFORMIS INC | $58.0M |
TKCTURKCELL ILETISIM HIZMETLERI | $58.0M |
GLTOUSDGALECTO INC | $56.0M |
IDIEURFLUENT INC | $56.0M |
—CHIASMA INC | $56.0M |
XELBUSDXCEL BRANDS INC | $55.0M |
AHTASHFORD HOSPITALITY TR INC | $55.0M |
—ACER THERAPEUTICS INC | $54.0M |
—APTINYX INC | $53.0M |
—CIDARA THERAPEUTICS INC | $52.0M |
—CHECKPOINT THERAPEUTICS INC | $48.0M |
SLDBSOLID BIOSCIENCES INC | $47.0M |
ENZBENZO BIOCHEM INC | $47.0M |
—PDL BIOPHARMA INC | $46.0M |
—VTV THERAPEUTICS INC | $46.0M |
—CALYXT INC | $45.0M |
FNHCUSDFEDNAT HLDG CO | $45.0M |
BMRAUSDBIOMERICA INC | $43.0M |
MNOVMEDICINOVA INC | $43.0M |
—SUMMIT WIRELESS TECH INC | $42.0M |
—ACELRX PHARMACEUTICALS INC | $41.0M |
—HARBOR CUSTOM DEVELOPMENT IN | $41.0M |
ADMAADMA BIOLOGICS INC | $40.0M |
PHPNGALECTIN THERAPEUTICS INC | $40.0M |
TMDEURTITAN MED INC | $40.0M |
MFGMIZUHO FINANCIAL GROUP INC | $38.0M |
ABIOEURARCA BIOPHARMA INC | $38.0M |
GOROGOLD RESOURCE CORP | $37.0M |
—THERMOGENESIS HLDGS INC | $36.0M |
PLXPROTALIX BIOTHERAPEUTICS INC | $33.0M |
—GTT COMMUNICATIONS INC | $32.0M |
—BORQS TECHNOLOGIES INC | $29.0M |
—AERPIO PHARMACEUTICALS INC | $29.0M |
—SEELOS THERAPEUTICS INC | $29.0M |
OPGNOPGEN INC | $29.0M |
—LIPOCINE INC NEW | $29.0M |
—SOLENO THERAPEUTICS INC | $28.0M |
ONSGBPOUTLOOK THERAPEUTICS INC | $27.0M |
DAREDARE BIOSCIENCE INC | $27.0M |
—AVENUE THERAPEUTICS INC | $27.0M |
—WASHINGTON PRIME GROUP NEW | $26.0M |
—ATHERSYS INC NEW | $26.0M |
—T2 BIOSYSTEMS INC | $25.0M |
—EVOFEM BIOSCIENCES INC | $24.0M |
—SURGALIGN HOLDINGS INC | $23.0M |
—CASI PHARMACEUTICALS INC | $22.0M |
—9 METERS BIOPHARMA INC | $22.0M |
OSG1EUROVERSEAS SHIPHOLDING GROUP I | $21.0M |
—TYME TECHNOLOGIES INC | $20.0M |
—SAFE T GROUP LTD | $19.0M |
—CHECK CAP LTD | $19.0M |
—US WELL SERVICES INC | $17.0M |
PreviousPage 8 of 8